The therapeutic process in psychological treatments for eating disorders: a systematic review by Brauhardt, Anne et al.
THERAPEUTIC PROCESS IN ED 
 
Brauhardt, Anne1, de Zwaan, Martina2, and Hilbert, Anja1 
 
1 Leipzig University Medical Center, Integrated Research and Treatment Center 
AdiposityDiseases; Philipp-Rosenthal-Strasse 27, 04103 Leipzig (Germany) 
2  Hannover Medical School, Department of Psychosomatic Medicine and 
Psychotherapy; Carl-Neuberg-Strasse 1, 30625 Hannover (Germany) 
 
Correspondence concerning this manuscript should be addressed to Anne Brauhardt, MSc, 
Leipzig University Medical Center, Integrated Research and Treatment Center 
AdiposityDiseases, Medical Psychology and Medical Sociology, Philipp-Rosenthal-Strasse 
27, 04103 Leipzig (Germany). 
Email: anne.brauhardt@medizin.uni-leipzig.de 
Phone: +49 341 97 15364 
Fax: +49 341 97 15378 
 
This is the peer reviewed version of the following article:  
 
Brauhardt, Anne; Zwaan, Martina de; Hilbert, Anja (2014): The therapeutic process in  
psychological treatments for eating disorders: A systematic review. In: Int. J. Eat. Disord.  
47(6), S. 565–584. DOI: 10.1002/eat.22287. 
 
which has been published in final form at http://dx.doi.org/10.1002/eat.22287. 
This article may be used for non-commercial purposes in accordance with Wiley Terms and  
Conditions for Self-Archiving  
[Link to: http://olabout.wiley.com/WileyCDA/Section/id-828039.html]. 
 
 
THERAPEUTIC PROCESS IN ED 
 
RUNNING HEAD: THERAPEUTIC PROCESS IN ED 
ABSTRACT 
Objective: For eating disorders, a vast number of investigations have demonstrated 
the efficacy of psychological treatments. However, evidence supporting the impact of 
therapeutic process aspects on outcome (i.e., process-outcome research) has not been 
disentangled.  
Method: Using the Generic Model of Psychotherapy (GMP) to organize various 
process aspects, a systematic literature search was conducted on psychological treatment 
studies for anorexia nervosa, bulimia nervosa, binge-eating disorder, and eating disorders not 
otherwise specified.  
Results: Improved outcomes resulted for family-based treatment compared to 
individual treatment, for individual compared to group treatment, booster sessions, and 
positive patient expectations (GMP contract aspect); for nutritional counseling and exercising 
but not exposure with response prevention as adjunct interventions (therapeutic operations); 
for highly motivated patients and, to a lesser extent, for therapeutic alliance (therapeutic 
bond); as well as for rapid response and longer overall treatment duration (temporal patterns). 
Regarding other GMP aspects, studies on self-relatedness were completely lacking and in-
session impacts were rarely investigated. 
Discussion: As most studies assessed only a limited number of process aspects, the 
ability to draw conclusions about their overall impact regarding outcome is rather limited. 
Therefore, future process-outcome research is needed beyond investigations of treatment 
efficacy for eating disorders. 
Key words: psychotherapeutic process; eating disorders; anorexia nervosa; bulimia 
nervosa; binge-eating disorder
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THE THERAPEUTIC PROCESS IN PSYCHOLOGICAL TREATMENTS FOR EATING 
DISORDERS: A SYSTEMATIC REVIEW 
 
Over the past decades, vast evidence has supported the efficacy of psychological 
treatments (i.e., outcome research). This research informed the publication of comprehensive 
psychological treatment guidelines of mental disorders, including eating disorders, in the US 
(American Psychiatric Association [APA]; 1), the UK (National Institute of Clinical 
Excellence [NICE];  2), and Germany (Association of the Scientific Medical Societies 
[AWMF]; 3). These guidelines highlight the importance of the therapeutic alliance as a 
process aspect in order to achieve better symptom reduction (e.g., 3). However, broader 
considerations of process aspects contributing to treatment outcome (i.e., process-outcome 
research) are lagging behind.  
Extensive systematic reviews on process aspects and outcome across various mental 
disorders by Orlinsky et al. (4) led to a comprehensive framework for process-outcome 
research. Thus, the “Generic Model of Psychotherapy” (GMP) offers “a map to guide the 
investigation of therapeutic change agents” (5; p. 365). The model contains various process 
aspects, all of which describe actions and experiences of patients and therapists in their joint 
interaction within, as well as between, therapeutic sessions. Based on the current literature, 
the GMP constitutes the only available global model to classify a broad range of process 
aspects in their relation to outcome. The GMP is composed of three levels (see Figure 1). 
While the top level describes “inputs” in terms of procedural prerequisites (e.g., the existing 
health care system, characteristics of patients and therapists), the bottom level encompasses 
“outputs” in terms of short and long-term outcomes. The mid-level process aspects are 
hypothesized to contribute to these outcomes. In addition, interactions of process aspects can 
positively or negatively influence outcome. Overall, Orlinsky et al. (4) described six process 
aspects within the GMP. First, they proposed the therapeutic contract as the organizational 
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process aspect, defining patients’ and therapists’ roles as well as the framework for their joint 
interaction. Second, therapeutic operations encompass the technical aspects, including the 
applied procedural tasks as well as the patient’s problem presentation and the therapist’s 
expert understanding of these problems. Third, the therapeutic bond, as the interpersonal 
aspect, represents two rather distinct domains, including the patient’s and the therapist’s 
treatment motivation as well as the quality of their interaction (i.e., the therapeutic alliance). 
The interaction quality further refers to the group cohesion or climate as the qualitative 
interaction between members in group treatment. Fourth, the intrapersonal aspect of self-
relatedness is understood as the patient’s and therapist’s self-experience within activities and 
relationships (e.g., one’s openness or defensiveness). Fifth, the clinical aspect of in-session 
impacts subsumes the patient’s and therapist’s positive and negative experiences within 
sessions (e.g., insight or emotional relief as positive realizations and confusion or distress as 
negative harms). Secondary to this aspect, impacts occurring between sessions based on the 
in-session impacts are included (i.e., inter-session impacts). Sixth, temporal patterns, as the 
sequential aspect, describe domains of session development and the course of treatment. The 
first five process aspects are depicted in Figure 1 with arrows corresponding to hypotheses 
about process-outcome relations. In contrast, temporal patterns cannot be shown, as they 
represent functions of time and patterns.  
Orlinsky et al. (4) emphasized positive as well as negative impacts of process aspects 
on outcome across various mental disorders. However, to our knowledge, systematic 
investigations summarizing the process-outcome research regarding psychological treatments 
of eating disorders, including anorexia nervosa (AN), bulimia nervosa (BN), binge-eating 
disorder (BED), and eating disorders not otherwise specified (EDNOS), are lacking. Hence, 
this article sought to systematically review the associations between process aspects and 
outcomes (i.e., changes in key symptoms of eating disorders) as outlined in the GMP.  
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METHOD 
Search and study selection 
This systematic review was conducted according to the PRISMA guidelines (6). In 
September 2013, relevant studies were identified using electronic databases (PSYCINFO and 
MEDLINE). Search terms included key words for all eating disorders, psychological 
treatments, and process parameters as outlined by Orlinsky et al. (4). Relevant articles were 
cross-referenced and systematic reviews and meta-analyses (including the psychological 
treatment guidelines for eating disorders, Cochrane reviews) were examined in order to 
identify additional studies. Article titles and abstracts were screened and the remaining full-
text articles were assessed for eligibility. Figure 2 further illustrates the literature search. 
 
Eligibility criteria 
To be included in the present systematic review, studies had to (1) investigate a patient 
sample with eating disorders (AN, BN, BED, or EDNOS1), diagnosed according to the 
Diagnostic and Statistical Manual of Mental Disorders, third edition or later (DSM; 7) or the 
International Classification of Diseases, ninth edition or later (ICD; 8; hence, studies had to be 
published after 1980), (2) contain a description of a psychological treatment, (3) explicitly 
report at least one process aspect that could be integrated into the scheme of Orlinsky et al. 
(4), (4) explicitly report at least one outcome (i.e., eating disorder key symptom), (5) have a 
sample size n > 3 in order to exclude case reports (cf. 9), and (6) had to be published in 
English or German language. Studies were excluded if they reported qualitative process 
aspects and/or outcome only or if they included patient samples with other mental disorders as 
primary diagnoses and eating disorders as associated diagnoses. 
The key symptoms for eating disorders assessed within studies at either end of 
treatment (EOT) or at follow-up (FU) were further operationalized as (a) weight gain for AN 
(e.g., weight, body mass index [BMI], percent of ideal or expected body weight), (b) binge 
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frequency for BN and BED, (c) purge frequency for BN, and (d) binge and/or purge 
frequency for EDNOS. Additionally, composite scores (e.g., Morgan-Russell scores for AN) 
were considered if they included at least one of the key symptoms above (a-c). Other 
outcomes included recovery (i.e., sustained remission) and relapse after achieved remission 
(i.e., reccurrence of key symptoms). Based on the consensus of all authors and in accordance 
with previous publications (e.g., 10, 11), outcome definitions also included remission 
operationalized as abstinence from key symptoms or achievement of a certain BMI cut-off 
(usually 17.5kg/m2). Secondary aspects of remission (e.g., eating disorder psychopathology 
within 1 SD of the healthy range) were not accounted for in the present review, as 




A total of 123 studies met the inclusion criteria comprising a total of n = 13,882 
patients (95.7% female), with sample sizes ranging from n = 16 to 2,000 patients (MW = 
114.11, SD = 212.77). Studies focused on BN (n = 61), AN (n = 52), BED (n = 21), and/or 
EDNOS (n = 12)2. While a majority of the studies included adult patients (n = 91), 33 studies 
focused on adolescents, and four studies investigated both age groups. The most prominent 
psychological treatments provided were cognitive-behavioral therapy (CBT; n = 66), family-
based treatment (FBT; n = 29), psychodynamic treatment (n = 14), interpersonal 
psychotherapy (IPT; n = 9), and self-help programs (SH; n = 9)2. Most studies looked at 
outpatient treatment (n = 97), while 15 studies examined day clinic treatment, and 23 studies 
examined inpatient treatment. The majority of studies were randomized-controlled trials 
(RCTs; n = 81). Other designs included controlled designs (n = 12) and naturalistic designs (n 
= 30). Studies providing FU assessments of patients (n = 40) had a mean FU length of 1.75 
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years (SD = 1.48). The mean dropout rate reported across studies was 18.8% (SD = 1.8; based 
on 102 reports; range: 0.0 to 60.7%). 
Characteristics and results of each study are summarized in Table 1 of this review. 
 
Therapeutic contract 
A total of n = 40 studies focused on the association between therapeutic contract as the 
organizational process aspect and outcome, including the three aspects of contractual 
provisions (i.e., setting, modality, intensity, and booster; n = 30), patient role (n = 7), and 
therapist role (n = 3). The majority of studies included RCTs (n = 35), while only two 
controlled and three naturalistic investigations were available (see Table 1).  
Treatment setting/modalities/third-party involvement. The impact of setting on 
outcome was assessed in n = 7 studies, including one study on adolescents. Studies compared 
outpatient to inpatient treatment (12, 13), outpatient to day clinic treatment (14), and day 
clinic to inpatient treatment (15-20). Overall, no consistent differences in outcome (i.e., 
weight gain, binge/purge frequency, remission) were found between settings and results 
varied considerably across eating disorder diagnoses (AN, BN, and EDNOS) and time of 
outcome assessment (i.e., EOT and FU). Comparisons of settings for the treatment of BED 
were lacking. Conclusions were limited due to high dropout rates reported for inpatient 
treatment in both adult and adolescent samples (12, 13).  
Treatment modalities were investigated in n = 6 studies with adult samples only. 
Modality refers to the size and composition of therapeutic interactions (i.e., if patients are 
treated individually or in groups; 4). Across studies, individual treatment resulted in better 
outcome (i.e., lower binge/purge frequency, higher remission) at EOT and FUs, when 
compared to group treatment, in five out of six studies on BN, BED, and EDNOS (21-26). 
The remaining study reported similar outcome for both individual and group modalities (27). 
Treatments included CBT (21-23, 25), a combination of CBT and motivation enhancement 
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therapy (MET; 24), or a combination of CBT and IPT (26, 27). Modality comparisons were 
not available for AN.  
Third-party involvement as a second modality aspect was examined in n = 11 studies. 
All but two investigated adolescent samples. These studies compared the participation of 
close relatives or spouses and parents to individual treatment. No outcome differences (i.e., 
weight gain, binge frequency, remission) were found for participation of close relatives or 
spouses in FBT for adults with AN (28) or for participation of spouses in group CBT for BED 
(29) and individual treatment. For adolescents with AN and BN, third-party involvement in 
FBT yielded better outcome (i.e., higher weight gain, Morgan-Russell scores, remission) in 
five out of eight studies at EOT and FUs (30-37). For the remaining studies, no differences 
between FBT and individual treatment emerged for AN and BN (35-41). Further, when 
comparing two versions of FBT in terms of conjoint or separate family sessions, Morgan-
Russell scores were comparable (39, 40). To date, research on the efficacy of FBT in 
adolescents with BED is lacking.   
Treatment intensity/booster sessions. In regards to aspects of time, examinations of 
treatment intensity (i.e. number of sessions per week) led to conflicting results. Only one of 
two studies found a positive association with outcome (i.e., remission) for adults with BN 
receiving outpatient CBT (42, 43). In contrast, the effect was absent in a large multicenter 
study of inpatient psychodynamic treatment for AN and BN (44). A second aspect of 
treatment intensity concerned the provision of booster sessions after a full course of initial 
treatment. Two out of four studies on adults with BN and BED receiving CBT reported 
improved outcome (i.e., lower binge frequency and relapse) when compared to patients not 
receiving additional sessions (45-46). Interestingly, in the remaining two trials, patients with 
BN did not benefit from booster sessions or did not engage in booster sessions (47, 48). 
However, the authors argued that “simply telling” (48; p. 549) patients about the availability 
of boosters might not have been motivating enough to engage in additional treatment.  
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Patient role. Contractual provisions regarding the patient’s role were assessed in seven 
studies, with one containing an adolescent sample. Patients’ ratings of treatment suitability as 
fit for treatment and patient (4) did not predict outcome (i.e., binge/purge frequency, 
remission) in four studies for adults with BN and BED receiving CBT or IPT (49-51) and 
adolescents with BN receiving FBT (52). Patients’ positive outcome expectations (i.e., 
expecting to be completely better after treatment; 53) were found to be associated with better 
outcome (i.e., lower binge/purge frequency, higher remission) for adults with BN in one study 
but not another (54, 55). Findings were also insignificant for adolescents with BN (52). 
Further, patients’ premature termination of treatment was investigated in direct relation to 
outcome in only one study and resulted in less weight gain at EOT when compared to patients 
receiving the full course of treatment (56). Other patient role aspects (e.g., patients’ verbal 
behavior) have not been investigated to date. 
Therapist role. Few studies were available regarding aspects of the therapist’s role (n 
= 3) and all three assessed the association of therapist adherence and outcome in adults with 
BN. Adherence can be defined as the extent to which an intervention is delivered by a 
therapist as outlined in the treatment manual or model (57) and is commonly rated by external 
observers in order to establish experimental validitiy in RCTs. Overall, adherence to CBT or 
to psychodynamic treatment protocols was not related to outcome (i.e., purge frequency, 
remission from purging; 58-60). However, individualized CBT, implying a reduced 
adherence, led to higher remission from binge eating (58). To date, research regarding 
adherence-outcome associations for AN and BED, as well as other aspects of the therapist’s 
role (e.g., therapist skills or verbal behavior), is lacking.  
 
Therapeutic operations 
Associations between therapeutic operations as the technical process aspect and 
outcome were investigated in n = 21 studies, including the three aspects of therapist focus (n 
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= 3 studies), adjunct exposure with response prevention (ERP; n = 7), and other adjunct 
interventions (n = 11). Study designs were predominantly RCTs (n = 15), with only three 
controlled and three naturalistic investigations (see Table 1).  
Therapist focus. The therapist’s focus describes the expert understanding of the 
patient’s problems and the topic that the therapist refers to within the treatment (4). One study 
directly compared an adjunct, symptom-oriented approach to inpatient psychodynamic 
treatment without the adjunct approach (61). The remaining two studies examined audio-
taped sessions (62) or therapists’ self-reports (63). Symptom-oriented approaches consistently 
led to higher weight gain in psychodynamic inpatient treatment for AN (61, 63). Focusing on 
interpersonal problems also predicted weight gain, while a self-conceptual focus was 
negatively associated with outcome (63). Furthermore, a focus on behavioral interventions 
within CBT for BN resulted in substantial but insignificant symptom reductions (62). Overall, 
a lack of RCTs including larger sample sizes and studies on BED was evident. 
Therapeutic interventions: Exposure treatments. ERP, as an adjunct therapeutic 
technique or operation, was repeatedly investigated in its relation to outcome by directly 
comparing standard treatment with and without ERP. Overall, findings on adjunct ERP were 
inconclusive as only three out of seven studies reported an advantage of adjunct ERP as 
compared to standard treatments. Adjunct ERP to binge and/or purge cues within CBT-related 
treatments for BN, compared to CBT alone, was associated with improved outcome in two 
out of five studies (i.e., lower binge/purge frequency, weight gain; 64-67). However, in one of 
the studies, outcomes did not differ at EOT but at the 5-year FU (67). In contrast, three studies 
conducted earlier did not yield differences for CBT with and without adjunct ERP (68-70).  
A similar comparison of ERP, regarding the fear of weight gain or relaxation as 
adjuncts, to inpatient treatment of AN resulted in higher remission at FU, but not EOT, when 
ERP was part of the treatment protocol (71). In BED, ERP to body image cues was compared 
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to cognitive restructuring as adjuncts to CBT; however, both interventions resulted in similar 
remission rates (72). 
Other therapeutic interventions. A limited number of studies examined adjunct 
interventions other than ERP in eating disorder treatment. Adjunct MET, an approach derived 
from the treatment of patients with addictions (73), did not result in better outcome (i.e., lower 
binge/purge frequency, higher weight gain, remission) in two investigations of CBT (74) or 
inpatient treatment (75) for AN and BN. In contrast, lower binge frequency and higher 
remission were reported when combining MET and SH for BED compared to SH alone (73). 
Better outcome (i.e., lower binge frequency, higher remission) was also reported in two of 
three studies examining adjunct nutritional counseling and exercising with CBT or a newer 
approach of emotion-focused therapy for BN (76) and BED (46,77). Another study did not 
report outcome differences in patients with and without adjunct nutritional counseling (78). 
Other adjunct interventions (e.g., ecological momentary assessment, behavioral instruction) 
did not differentially affect outcome (79, 80). However, providing feedback in SH resulted in 
a lower purge frequency but not a lower binge frequency for patients with BN (81). A single 
investigation on adjunct interventions for adolescents with AN, offering additional contact 
between parents of recovered adolescents and parents of adolescents with a current diagnosis 
undergoing FBT, did not report differential weight gain, however, a steeper increase in weight 
gain was observed (82).  
Despite substantial evidence regarding the operations-outcome relationship, no study 
was identified investigating other GMP process aspects, for example, patients’ problem 
presentation (e.g., focus, behavior, or responsiveness) or other therapist interventions (e.g., 
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Therapeutic bond 
A total of n = 30 studies examined the therapeutic bond as the interpersonal process 
aspect, including the three aspects of motivation (n = 16), therapeutic alliance (n = 13), and 
group cohesion/climate (n = 4)3. Studies on motivation included primarily naturalistic studies 
(n = 11), four RCTs, and one controlled study. Alliance-outcome relationships were mostly 
investigated in RCTs (n = 11) and two naturalistic studies. Regarding group cohesion/climate, 
study designs included two RCTs, one naturalistic study, and one controlled study (see Table 
1). 
Motivation. Motivation to engage in psychological treatments encompasses the level 
of personal engagement of patient and therapist and is commonly operationalized as readiness 
to change (83). Regarding patients’ self-rated motivation, studies consistently reported better 
outcome (i.e., lower binge/purge frequency, higher weight gain, remission, recovery) for 
highly motivated patients when compared to patients with reduced levels of motivation in 
eight out of nine studies in adults (24, 84-90) as well as in four out of five studies in 
adolescents (91-94) across various psychological treatments (e.g., CBT, SH, FBT, and IPT) 
for AN, BN, and EDNOS. Across studies, motivation appeared to be more closely linked to 
improvements in binge frequency than purge frequency. The remaining studies did not report 
significant motivation-outcome associations (95-98). Overall, findings varied across outcome 
(e.g., binge or purge frequency) or time of assessment. The remaining studies did not report 
significant associations (74, 95-97). In contrast, investigations for BED were lacking. While a 
substantial number of studies were conducted on patients’ motivation, evidence on therapists’ 
motivation is also not available. 
Therapeutic alliance. Therapeutic alliance is commonly defined as the collaborative 
and affective bond between therapist and patient (98). Despite a large number of 
investigations on alliance-outcome associations, findings were widely inconsistent across 
eating disorder diagnoses, treatments, patient age groups, and time of assessment (e.g., early 
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vs. mid vs. late treatment; 99). In only four out of ten studies, higher alliance ratings from 
either patient ratings or external observers predicted better outcome (i.e., lower binge/purge 
frequency, higher remission) for patients with BN receiving CBT, IPT, or MET (50, 59, 89, 
99). Alliance ratings were not related to outcome in other studies on BN (51, 95, 100), BED 
(49, 101) or adults with AN (102). Investigations on adolescents with AN and BN reported 
positive alliance-outcome associations in all four conducted studies (52, 103-107). However, 
findings varied between ratings perspectives from adolescents, mothers, or fathers. Overall, 
alliance was commonly measured via self-report, while only a minority of studies utilized 
external observer ratings. Therapist ratings of alliance were not available in any of the 
included studies. 
Group cohesion/climate. Group cohesion/climate encompasses the relationship 
between group members and their sense of cohesion with other patients (108) in addition to 
the patient-therapist alliance. Cohesion/climate was investigated in four studies with all but 
one including only adult patients. Findings showed positive associations of cohesion/climate 
and outcome (i.e., lower binge/purge frequency, higher weight gain, remission) in three 
studies delivering CBT, IPT, and psychodynamic treatment to BED (49, 109, 110). The 
remaining study, offering CBT to patients with AN, BN, and EDNOS, did not report positive 
outcome relations (96). Despite the positive associations for BED, results varied across time 
of assessment (e.g., early vs. mid vs. late treatment; 109).  
In conclusion, the therapeutic bond was extensively investigated. However, other 
aspects of the bond as outlined in the GMP, for example, the interactive coordination (i.e., 
how patient and therapist function as a team), expressive attunement (i.e., communication 
quality), and the affective attitude of patients and therapists have not received any attention in 
the present studies. 
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Self-relatedness 
Based on our literature search, we were not able to identify a study investigating the 
association of patient and/or therapist self-relatedness as the intra-personal process aspect 
(i.e., the patients’ or therapists’ inner psychological state during sessions) and outcome.   
 
In-session and inter-session impacts 
Associations of in-session and inter-session impacts and outcome were investigated in 
a total of four studies with adult patients only. Study designs included one RCT, two 
controlled studies, and one naturalistic study (see Table 1).   
In-session impacts. In-session impacts concern the patients’ and therapists’ positive 
and negative experiences, thus, resulting in clinically relevant consequences based on the 
therapeutic operations as well as on the achieved therapeutic bond within treatment sessions 
(4). Findings were inconsistent within the small number of studies examining in-session 
impacts in inpatient treatment of AN and BN. While one study found negative emotions to 
predict negative outcome (i.e., less weight gain) for inpatient treatment of AN (63), another 
study reported the absence of statistically significant associations for patients with BN and 
EDNOS receiving CBT and psychodynamic treatment (111). Negative experiences, in terms 
of more painful challenges in BN, were linked to non-remission. In contrast, positive outcome 
for BN (i.e., lower binge/purge frequency, higher remission) was predicted by positive in-
session impacts, for example, positive outcome expectations (100), experiencing self-efficacy, 
fewer dysfunctional beliefs, and more positive emotions (111). However, associations varied 
considerably over the course of treatment (i.e., early vs. mid vs. late treatment; 100).   
Inter-session impacts. Patients’ and therapists’ experiences, with respect to each other 
between sessions (4), were investigated together with in-session impacts in three studies. 
Frequent or intense inter-session experiences, such as recreating the therapeutic dialogue, 
predicted greater weight gain in AN (63). In contrast, frequent dialogue recreations resulted in 
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greater likelihood of non-remission from BN (100). Furthermore, patients with BN thinking 
about sessions more often (100) and patients with BED exhibiting more positive (e.g., hope 
and relief) and fewer negative emotions (e.g., lack of emotional distress; 109) showed better 
outcome (i.e., higher remission) compared to those who did not report these positive inter-
session impacts. Again, however, effects varied strongly over the course of treatment (i.e., 
early vs. mid vs. late treatment; 100, 109). 
Despite the initial findings and the postulated occurrence of impacts for both the 
patient and therapist (4), studies were limited to the patient’s experiences. In addition, 
investigations were also restricted as certain aspects, thus, insight and problem resolution as 
other process aspects have not been examined. Furthermore, findings should be considered 
preliminary as most studies included small patient samples.  
 
Temporal patterns 
A total of n = 37 studies examined the relationship between temporal patterns as the 
sequential process aspect, including the two aspects of symptom change/rapid response (n = 
19) and treatment dose effects/duration (i.e., time spent in treatment; n = 18), and outcome. 
The majority of studies were RCTs (n = 19) and naturalistic studies (n = 13). Further, a few 
controlled studies (n = 5) were conducted (see Table 1).  
Symptom change/rapid response. Symptom change early in treatment or rapid 
response is commonly defined as binge/purging reduction of 65 to 80% or a steep weight gain 
within the first four to six weeks of treatment (e.g., 112, 113). A substantial number of studies 
examined rapid response across various treatments (e.g., CBT, IPT, DBT, and SH) for adults 
with AN, BN, BED, and EDNOS. Patients classified as rapid responders showed better 
outcome at EOT (i.e., lower binge/purge frequency, higher weight gain, remission, recovery) 
when compared to patients not exhibiting these early symptom reductions in 15 out of 15 
studies (55, 100, 101, 112-124). Interestingly, results at FU assessments showed more 
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variation. Rapid responders and non-rapid responders were found to show similar outcome at 
FU. Thus, authors suggested a delayed treatment response in non-rapid responders (e.g., 101). 
In addition, rapid response effects on outcome were also found in two out of three studies on 
adolescents with AN and BN receiving FBT (125, 126), while rapid responders and non-rapid 
responders achieved comparable remission in the remaining study on AN (127).   
Treatment dose effects/duration. The overall time spent in treatment can be 
operationalized in several ways across studies. Dose effects, encompassing the number of 
sessions attended or the patient’s compliance to work on treatment modules in SH programs 
(e.g., completion of all modules vs. partial completion; 128), were investigated in eight 
studies. For adults with AN, BN, and BED undergoing outpatient psychological treatments, 
results were inconsistent as only two out of five studies found positive attendance-outcome 
associations (29, 128). The remaining studies did not show any outcome differences for 
patients with higher versus lower attendance (49, 102, 129). Regarding compliance in SH, two 
out of three studies showed better outcome for adults with AN (129) and BN (131) when 
more SH modules were worked on. In contrast, patients with higher versus lower compliance 
did not differ in their outcome in the remaining study on SH for BN (132). 
Another aspect of time spent in treatment included the overall duration of commonly 
open-end treatments. Longer duration positively predicted outcome in four out of four studies 
on adults with AN, BN, and EDNOS (15, 44, 56, 60). Opposed to this rather consistent 
finding, longer treatment duration resulted in negative outcome (i.e., less weight gain or lower 
recovery rates) for adolescents with AN (94, 133). When directly comparing shorter versus 
longer treatment conditions, studies yielded inconsistent results. While improved outcome 
was shown for longer CBT for adult patients with BED (123) as well as FBT and SPT for 
adolescents with AN (134), another study on adolescent AN did not find a significant 
association (135, 136). A comparison of shorter to longer day clinic treatment (i.e., four vs. 
five days per week) for adult AN, BN, and EDNOS found higher weight gain for the short 
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condition, while lower binge frequency and higher remission was achieved in the longer 
treatment condition (137).  
Besides the substantial research supporting a rapid response-outcome relationship, 




This systematic review compiled the current literature on process-outcome research in 
psychological treatments for eating disorders. Numerous associations across eating disorder 
diagnoses and treatments were in support of Orlinsky et al.’s GMP (4). Overall, improved 
outcome resulted for (1) FBT compared to individual treatment, individual compared to group 
treatment, booster sessions, and positive patient expectations as aspects of the therapeutic 
contract, (2) adjunct nutritional counseling and exercising, but not ERP, as aspects of 
therapeutic operations, (3) patients with high motivation and, to a lesser extent, higher 
therapeutic alliance as aspects of the therapeutic bond, and (4) rapid response and longer as 
opposed to shorter overall treatment duration as aspects of the temporal patterns. Multiple 
further aspects were inconsistently related to outcome. Conversely, findings on self-
relatedness were lacking and in-/inter-session impacts were rarely investigated. 
Regarding the therapeutic contract, few studies on outpatient, day clinic, and inpatient 
treatment for AN and BN were available and results were inconsistent. Across various mental 
disorders, findings were more cohesive and no outcome differences were found in the 
majority of studies included in the review by Orlinsky et al (4). In contrast to the conclusions 
of Orlinsky et al. (4), individual treatment modalities for eating disorders were shown to be 
superior to group treatment. Similarly, recent investigations also found slight advantages for 
individual treatment in patients with depression (cf. 138, 139). Further, participation of family 
members in treatment as third-party involvement resulted in better outcome in adolescents 
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with eating disorders (i.e., FBT), but not in adults. In contrast, similar outcome was reported 
by Orlinsky et al. (4) for individual treatments when compared to FBT and the participation of 
spouses in couples therapy. Accordingly, couples therapy and individual CBT and IPT for 
patients with depression did not differ in terms of outcome either (140). Despite an earlier 
meta-analysis showing higher session frequencies to be associated with better outcome for 
BN (141), studies on treatment intensity in the present review were rare and prohibited further 
conclusions. Conversely, booster sessions positively predicted outcome in the present review 
and GMP literature (4). However, as stated by Orlinsky et al. (4), intensity and booster 
sessions might also influence outcome through interactions with other process aspects (e.g., 
overall treatment duration). Concerning the therapist’s role, adherence was not found to be 
related to outcome in eating disorders. This reflects findings from a meta-analysis across 
various mental disorders (49). In contrast, modest but overall positive adherence-outcome 
associations have been reported across a substantial number of studies reviewed by Orlinsky 
et al. (4) and were also found in recent investigations of treatments for patients with 
depression (142). While patient-rated suitability of treatment and positive outcome 
expectations, as aspects of the patient’s role, were identified to predict outcome in the GMP 
literature (4), only patient expectations were positively related to outcome in eating disorders. 
In addition, high ratings of suitability were shown to predict treatment dropout for BN (143). 
Overall, studies regarding the contract aspects of setting, patient’s role, and therapist’s role 
can be described as lagging behind and more research on eating disorders is needed. This 
would also allow for further comparisons to the GMP literature and studies on depression, 
whereas conflicting findings across this research cannot yet be resolved.  
With respect to technical therapeutic operations, investigations of the therapist’s focus 
were sparse in the present review. Previously, this has also been pointed out for other mental 
disorders by Orlinsky et al. (4). Additionally, small sample sizes further limited the findings’ 
validity. A great number of operations-outcome studies investigated the efficacy of adjunct 
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ERP. However, non-significant outcome differences were found in a majority of publications. 
In contrast, improved outcome for ERP-based interventions has been reported by Orlinsky et 
al. (4) and in other recent reviews for anxiety disorders (144, 145). Overall, the lack of 
outcome differences for ERP in eating disorders might be attributable to substantial variations 
in the implementation of ERP (i.e., time point and length) that have also been previously 
underlined (146). Despite the lack of additive effects, adjunct ERP is popular in treatment of 
BN and BED and has been emphasized in recent treatment concepts (e.g., 147). In contrast to 
ERP, adjunct nutritional counseling and exercising resulted in improved outcome for BN and 
BED, though only a small number of studies were conducted. Besides impacts on key 
symptoms, studies also found improved secondary outcome (e.g., higher weight loss in BED; 
78). More research is needed, however, to validate this effect. Despite the initial 
demonstration of benefits from exercising (e.g., 148), exercising should be introduced 
carefully in cases of AN and BN as it might be used as inappropriate compensatory behavior 
and, hence, could sustain the eating disorder. To date, investigations on operations-outcome 
associations for adjunct interventions for adolescents with eating disorders and other aspects 
of therapeutic operations (e.g., patient’s and therapist’s role implementation) are lacking. 
Regarding role implementation, findings for other mental disorders were inconsistent as 
pointed out in the GMP literature (4) and thus, might be less promising in enhancing the 
overall treatment efficacy compared to other process aspects.  
A large number of process-outcome studies in eating disorders investigated the 
interpersonal therapeutic bond aspect concerning the two rather distinct concepts of 
motivation and therapeutic alliance. For patients with eating disorders, higher motivation to 
engage in treatment emerged as a robust predictor of outcome in both adults and adolescents. 
Furthermore, highly motivated patients completed treatments more often, while less 
motivated patients with eating disorders were more likely to drop out (97). The positive 
motivation-outcome association receives additional support from current reviews across 
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various mental disorders (83), including depression and anxiety disorders (e.g., 149). In 
contrast, consistent findings were reported by Orlinsky et al. (4) as they identified comparable 
numbers of studies to report either non-significant or positive associations. Despite the 
investigation in a large number of studies, alliance-outcome findings for adult samples with 
eating disorders were inconclusive as only about half the studies reported higher alliance 
ratings to predict improved outcome. Conversely, alliance in FBT repeatedly predicted eating 
disorder outcome for both adolescents and parents. Further research is needed to validate this 
effect as few investigations on adolescents were conducted. In contrast to findings for adults 
with eating disorders, but in line with results for adolescents, the GMP literature and several 
meta-analyses (e.g., 150, 151), as well as recent investigations in patients with depression 
(152), identified alliance as a robust predictor in the process-outcome research. However, 
interactions with symptom changes over the course of treatment were common in BN (51, 54) 
and depression (153). Within these studies, prior symptom reductions were identified as 
important prerequisites for subsequent increases of alliance and, hence, outcome at EOT. 
Regarding cohesion-outcome relations in group treatments for eating disorders, few studies 
have been conducted which precludes the evaluation of its effects. In turn, reviews (4, 154) 
and a current meta-analysis (108) across various mental disorders, including depression, 
reported positive cohesion-outcome associations. Thus, authors argue that positive group 
cohesion/climate should be established, especially for open group-formats, before new 
members might be introduced to the group (155).  
Surprisingly, no study was identified to investigate the patient’s and/or therapist’s 
intrapersonal self-relatedness regarding positive or negative impacts within sessions. In 
contrast, Orlinsky et al. (4) described a number of self-relational aspects to be associated with 
outcome across various mental disorders. For example, the patient’s openness was identified 
as a robust outcome predictor within the GMP literature as well as in more recent 
investigations of depression (156). However, findings on other aspects (e.g., self-congruence, 
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self-acceptance) were inconclusive. Based on this GMP research, studies in eating disorder 
treatment should be conducted in the future.  
Clinical in-session impacts received rather limited attention within the process-
outcome research on eating disorders. In line with findings from Orlinsky et al. (4) and recent 
investigations of depression (156, 157), the patient’s experiences of positive and negative 
emotions, self-efficacy, and intense reproduction of patient-therapist conversations led to 
improved outcome in eating disorders. Furthermore, initial evidence suggests that patients 
experiencing more harms or distress (i.e., low self-esteem, low mastery, and low clarification 
levels) were more likely to drop out of CBT for BED (158). Interestingly, initial analyses 
found in-session and inter-session impacts to account for substantial symptom reductions 
beyond the effects of patient characteristics (e.g., symptom severity, gender, age) or rapid 
response to treatment in BN (100). In addition, inter-session impacts affected outcome even 
more than in-session experiences. However, more research is warranted to confirm these 
effects for patients and also to investigate the therapist’s impact on outcome. Regarding 
therapists, impacts should be considered as they potentially influence psychological well-
being and, in consequence, the therapist’s treatment performance (4).   
Within the past decade, the investigation of associations between temporal patterns 
and outcome received substantial attention in eating disorders. Rapid response consistently 
predicted outcome across all eating disorder diagnoses, treatments, and age groups. Thus, 
rapid response could be considered “the most popular variable in process-outcome research 
along with global alliance” (4; p. 358). The examination of early symptom changes was 
primarily initiated by earlier studies on depression (159, 160) and more recent studies 
continue to find rapid response to be associated with outcome in the treatment of depression 
(160, 161). In addition, rapid response in patients with eating disorders was shown to account 
for substantial symptom reductions beyond the variability of symptom reductions accounted 
for by patients’ symptom severity and the overall treatment duration (112-114). In line with 
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findings for rapid response, both planned treatment duration and patients’ 
attendance/compliance to treatments repeatedly resulted in improved outcome across eating 
disorder diagnoses and treatments. While longer duration predicted more positive outcome for 
adults with eating disorders as well as other mental disorders (4), findings for adolescents 
were inconsistent. Furthermore, longer duration might not be invariably positive (4) as it was 
previously also related to higher dropout from treatment for BN (141).  
 
Strengths and limitations 
When interpreting the findings of the present review, several strengths and limitations 
should be taken into account. First, as our aim was to provide a broad overview on the current 
process-outcome research for eating disorders, inclusion and exclusion criteria were held to a 
minimum. Thus, we did not include “high quality”-studies only (i.e., RCTs) as they did not 
always seem appropriate when investigating process aspects. While, for example, settings, 
modalities, and adjunct interventions could be properly investigated in RCT designs, it does 
not seem ethical nor feasible to randomize patients to empathic, warm versus insensitive, 
indifferent therapists (4). A second limitation is the rather strict outcome definitions 
considering key symptoms only. Effects of process aspects on secondary outcome have also 
been reported within studies (e.g., eating disorder and associated general psychopathology) 
but could be not reported due to space limitations.  
Regarding the studies in this review, major methodological issues limited the 
interpretation and generalization of findings. First, the sample sizes of the included studies 
varied considerably. While most RCTs were sufficiently powered, other studies might have 
lacked the necessary sample size to detect significant process-outcome associations. In 
addition, substantial dropout rates were reported across studies, further limiting the 
interpretation of results. Second, brief treatment descriptions complicated the drawing of valid 
conclusions for individual psychological treatments. Third, assessment methods varied widely 
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across studies ranging from single item self-reports (e.g., to assess patients’ motivation), 
reliable and valid self-report or observer-ratings (e.g., Working Alliance Inventory to assess 
alliance [WAI]; 162) to clinical expert interviews to assess key symptoms of eating disorders. 
Various rating perspectives across process and outcome variables within one study could have 
further increased the variance of findings and the comparison between studies. 
 
Directions for future research 
While a substantial number of studies investigated the efficacy of psychological 
treatments for eating disorders, only a minority of these studies included investigations of 
process-outcome associations. Hence, more process-outcome research in psychological 
treatment of eating disorders is generally warranted. As indicated in this review (cf. findings 
on alliance), process aspects differentially influenced outcome for adolescents and adults. 
However, research regarding the efficacy of psychological treatments for adolescents with 
eating disorders is currently limited. Thus, future investigations should focus simultaneously 
on the establishment of treatment efficacy and process aspects. Recently developed internet-
based, guided SH represents another area of future process-outcome research (e.g., alliance; 
163, 164). So far, positive alliance-outcome relations have already been demonstrated for 
other mental disorders (e.g., 165, 166).  
Regarding various methodological aspects of the process-outcome research, process-
outcome research within efficacy studies can be based on repeated collection of process 
reports from patients and therapists. However, researchers might be reluctant to do so in order 
to minimize additional effort for both patients and therapists participating in their studies. 
Researchers could minimize these additional efforts by utilizing gold-standard external 
observer ratings (4) as was commonly done to investigate adherence and alliance. However, 
substantial expertise is needed to produce reliable and valid ratings of process aspects based 
on analyses of audio- or videotaped sessions (167). Nevertheless, these analyses could 
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facilitate the assessment of several process aspects at the same time (e.g., therapists’ 
adherence and competence, alliance, self-relatedness, in-session impacts). Observer based 
ratings of process aspects would further allow determining joint impacts as well as 
interactions of several process aspects on outcome (e.g., 100).  
Besides the general consideration of process research in future clinical trails, 
additional research venues should concern the inclusion of more male patients in treatments 
studies for eating disorders as they were found to be underrepresented in the current review 
(less than 5%). Further, researchers should apply reliable and valid measures to assess process 
aspects. So far, improvements of measurement validity appear to be necessary in certain areas 
(e.g., single items to assess expectations and motivation).   
 
Clinical Implications 
General recommendations for psychological treatments of patients with eating 
disorders have been provided by international guidelines (1-3). These guidelines have focused 
primarily on the process aspect of therapeutic alliance to achieve symptom reductions, while 
broader process consideration appears to be lacking. Hence, based on this review, several 
implications for clinical practice can be derived regarding contractual provisions of treatment; 
for example, FBT and individual treatments appear to be preferable treatments as better 
outcome was reported. During treatment, in order to improve outcome, therapists should try to 
intervene if they perceive a lack of motivation or a break in the patient-therapist alliance. 
Furthermore, therapists should aim for early symptom reductions. Based on the importance of 
rapid response, authors proposed triage algorithms for cases of BN (114): if patients do not 
rapidly respond to implemented first-line treatment within a defined time period (i.e., patients 
do not meet a proposed cut-off of sufficient symptom reduction), the therapist would be 
advised to change his/her approach and provide an alternative treatment. Further research is 
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necessary to establish evidence-based cut-offs regarding time periods and symptom 
reductions that can be used for individual treatment decisions. 
Overall, the current evidence on process-outcome associations is limited. Additional 
research is needed to allow for more precise conclusions regarding the “ingredients” of 
efficacious psychological treatments. 
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Footnotes 
1 As EDNOS no longer exists as a diagnostic category in the DSM-5, it was 
included based on its description in previous versions of the DSM. Criteria for EDNOS, 
generally describing patients with sub-clinical levels of eating disorders, might vary across 
included studies given the authors’ individual EDNOS criteria. 
2 Regarding the eating disorder diagnoses and the psychological treatments, 
studies do not add up to n = 126 as studies could have included patient samples with more 
than one eating disorder diagnosis or more than one treatment condition. 
3 Studies do not add up to n = 30 as three studies investigated patients’ 
motivation and therapeutic alliance or group cohesion (49, 89, 95).   
 
THERAPEUTIC PROCESS IN ED 
 
Tables 
Table 1. Summary of study results on process-outcome associations grouped by process aspects of the GMP. 






1. THERAPEUTIC CONTRACT  
Setting / modality sign: n = 14 / ns: n = 10 
Ball & Mitchell (2004) AN (n = 25) RCT CBT, FBT FBT vs. ind weight gain ns 





ind > group; FU(3/6m): 
ns 
Crisp et al. (1991) AN (n = 90) RCT CBT, FBT out vs. in weight gain ns 
Dare et al. (2001) AN (n = 84) RCT FBT, PA, CAT FBT vs. ind 
M-R score, weight 
gain, remission 
ns 





ind+group > group 
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Eisler et al. (2000, 
2007) 
AN (n = 40) RCT FBT 
conjoint vs. 
separated FBT 
M-R scores ns 
Godart et al. (2012) AN (n = 60) RCT FBT, TAU 
TAU+FBT vs. 
TAU 
weight gain, M-R 
scores 
FBT+TAU > TAU 










Katzman et al. (2010) 
BN, EDNOS 
(n = 225) 
RCT CBT, MET ind vs. group 
binge frequency ns 
purge frequency ind > group 
Kong (2005) 
AN, BN, 
EDNOS (n = 
50) 
RCT CBT day vs. out 
weight gain day > out 
binge/purge 
frequency 
day > out 
Le Grange et al. (1992) AN (n = 18) RCT FBT, SPT FBT vs. ind weight gain Ns 
Le Grange et al. (2007) BN (n = 80) RCT FBT, SPT FBT vs. ind remission FBT > ind 
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partial remission ns 
Lock et al. (2010) AN (n = 121) RCT FBT, AFT FBT vs. ind 
full remission 
ns; FU(6m/1y): FBT > 
ind 
partial remission 
FBT > ind; FU(6m/1y): 
ns 
Nevonen & Broberg 
(2005) 
EDNOS (n = 
35) 
RCT CBT, IPT ind vs. group remission, recovery ns 
Nevonen & Broberg 
(2006) 
BN (n = 86) RCT CBT, IPT ind vs. group 
binge/purge 
frequency 
ind > group 
Ricca et al. (2010) BED (n = 144) RCT CBT ind vs. group recovery ind > group; FU (3y): ns 
Richard (2005) 
AN, BN (n = 
2.000) 
nat no info available day vs. in remission AN: ns; BN: day > in 
Robin et al. (1994) AN (n = 24) RCT FBT, PD FBT vs. ind 
full remission ns 
partial remission FBT > ind; FU(1y): ns 
Robin et al. (1999) AN (n = 41) RCT FBT, PD FBT vs. ind full remission ns 
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partial remission FBT > ind; FU(1y): ns 
Russell et al. (1987); 
Dare et al. (1990); 
Eisler et al. (1997) 
AN, BN (n = 
80) 
RCT FBT, SPT FBT vs. ind 
M-R scores, weight 
gain, remission 
ns; early onset AN: FBT 
> ind  




Zeeck et al. (2006) AN (n = 36) con PD day vs. in 
weight gain, 
remission 
in > day 
Zeeck et al. (2009a, b; 
2011) 




ns; FU (1y): ns 
recovery FU (3y): day > in 
Intensity / booster sign: n = 3 / ns: n = 2 
Eldredge et al. (1997) BED (n = 46) RCT CBT booster binge frequency pos 
Kächele et al. (2001) 
AN, BN (n = 
1171) 
nat PD intensity recovery ns 
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Mitchell et al. (1993); 
Crosby et al. (1993) 
BN (n = 143) RCT CBT intensity remission pos 
Mitchell et al. (2004) BN (n = 57) RCT CBT booster - - -  not applicable 
Pendleton et al. (2002) BED (n = 88) RCT CBT booster binge frequency pos 
Pyle et al. (1990) BN (n = 68) RCT CBT booster relapse ns 
Patient role sign: n = 2 / ns: n = 5 
Hilbert at al. (2007) BED (n = 162) RCT CBT, IPT suitability remission ns 
Jones et al. (2007)  AN (n = 34) nat CBT termination weight gain pos 




Mussell et al. (2000) BN (n = 143) RCT CBT expectations remission pos 
Wilson et al. (1999) BN (n = 92) RCT CBT, SPT suitability remission ns 
Wilson et al. (2002) BN (n = 220) RCT CBT, IPT suitability remission ns 






Therapist role sign: n = 1 / ns: n = 2 
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ind > manual 
Loeb et al. (2005) BN (n = 110) RCT CBT adherence purge frequency ns 
Thompson-Brenner & 
Westen (2005) 




2. THERAPEUTIC OPERATIONS  
Focus sign: n = 2 / ns: n = 1 
Herzog et al. (1996) AN (n = 34) con PD symptom-oriented weight gain pos 
Spangler et al. (2004) BN (n = 56) RCT CBT behavioral purge frequency ns 
Zeeck & Hartmann 
(2005) 
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Exposure with Response Prevention (ERP) sign: n = 3 / ns: n = 4 
Agras et al. (1989) BN (n = 77) RCT CBT 
CBT+ERP vs. 
CBT 
purge frequency ns 
remission 
ns; FU(6m): CBT > 
CBT+ERP 
Bulik et al. (1998); 
Carter et al. (2003); 
McIntosh et al. (2011) 




ns; FU(3y): ns; FU (5y): 
ERP > Relax 
Goldfarb et al. (1987) AN (n = 18) RCT SPT 
in+ERP vs. 
in+Relax vs. in 
weight gain ns 
remission 








Leitenberg et al. (1988) BN (n = 47) RCT CBT 
CBT+ERPs vs. 
CBT 
purge frequency ns 
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Other Therapeutic Interventions sign: n = 5 / ns: n = 6 
Allen et al. (2012) 
AN, BN (n = 
95) 
con CBT, MET 
MET+CBT vs. 
CBT 
weight gain, purge 
frequency 
ns 
Cassin et al. (2008) BED (n = 108) RCT SH, MET MET+SH vs. SH 
binge frequency, 
remission 
MET+SH > SH 
Compare et al. (2013) BED (n = 189) nat EFT 
EFT+nutr vs. EFT 
vs. nutr 
remission EFT+nutr > EFT, nutr 
Dean et al. (2008) 
AN, BN (n = 
42) 







Hsu et al. (2001) BN (n = 100) RCT CT 





remission CT+nutr, CT > nutr 
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Masheb et al. (2011) BED (n = 50) RCT CBT CBT+nutr vs. CBT remission ns 
Pendleton et al. (2002) BED (n = 88) RCT CBT 
CBT+exercise vs. 
CBT 
binge frequency CBT+exercise > CBT 
Rhodes et al. (2008) AN (n = 20) RCT FBT FBT consultations recovery ns 
Schmidt et al. (2006) BN (n = 61) RCT SH 
SH+Feeback vs. 
SH 
binge frequency ns 
purge frequency SH+Feedback > SH 
Yates & Sambrailo 
(1984) 






3. THERAPEUTIC BOND  
Motivation sign: n = 12 / ns: n = 4 
Allen et al. (2012) 
AN, BN (n = 
95) 
con CBT, MET motivation binge frequency ns 
Ametller et al. (2005) AN (n = 70) nat CBT, FBT motivation weight gain pos 
Bell & Hodder (2001) BN (n = 40) nat SH motivation binge frequency pos 
THERAPEUTIC PROCESS IN ED 
 
purge frequency ns 
Bewell & Carter 
(2008) 
AN (n = 159) nat no info available motivation weight gain pos 
Castro-Fornieles et al. 
(2011) 
BN (n = 40) nat CBT motivation 
binge frequency pos 
purge frequency ns 
Crino & Djokvucic 
(2010) 
AN, BN, 
EDNOS  (n = 
36) 









Gowers & Smyth 
(2004) 
AN (n = 42) nat CBT motivation weight gain pos 
Katzman et al. (2010) BN (n = 225) RCT CBT, MET motivation 
binge frequency pos 
purge frequency ns 
Mander et al. (2013) AN (n = 39) nat CBT motivation weight gain ns 
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Mansour et al. (2012) BN (n = 155) nat 
combined CBT, 
IPT, DBT etc. 
motivation 
binge frequency pos 
purge frequency ns 
McHugh (2007) AN (n = 65) nat 
combined, 
including FBT 
motivation recovery pos 
Steele et al. (2011) BN (n = 87) RCT SH motivation 
binge frequency pos; FU: ns 
purge frequency ns 




Wade et al. (2009) AN (n = 33) nat CBT, MET motivation weight gain ns 
Wolk & Devlin (2001) BN (n = 110) RCT CBT, IPT motivation remission IPT: pos; CBT: ns 
Therapeutic Alliance sign: n = 8 / ns: n = 5 
Brown et al. (2013) AN (n = 65) nat CBT alliance weight gain ns 
Constantino et al. 
(2005) 
ΒN (n = 220) RCT CBT, IPT alliance purge frequency 
CBT: early, mid: pos; 
late: ns; IPT: mid: pos; 
early, late: ns 
Ellison et al. (2012) AN (n = 59) RCT FBT alliance weight gain mother: pos; father: neg 
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Forsberg et al. (2013a, 
b) 
AN (n = 
38/78) 
RCT FBT alliance 
full remission ns 
partial remission pos 
recovery ns 
Hartmann et al. (2010) BN (n = 55) RCT PD alliance remission ns 
Hilbert at al. (2007) BED (n = 162) RCT CBT, IPT alliance remission ns 
Isserlin & Couturier 
(2012) 
AN (n = 143) nat FBT alliance remission 
adolescent: ns; parent: 
pos 
Lock et al. (2008); 
Zaitsoff et al. (2008) 




FBT: ns; SPT: pos 
Loeb et al. (2005) 
 
BN (n = 110) RCT CBT alliance purge frequency early: pos; mid, late: ns 
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Wilson et al. (1999) BN (n = 92) RCT CBT, SPT alliance remission pos 




Group Climate / Cohesion sign: n = 3 / ns: n = 1 
Castonguay et al. 
(1998) 
BED (n = 75) con CBT climate remission early, mid: pos; late: ns 
Crino & Djokvucic 
(2010) 
AN, BN, 
EDNOS (n = 
36) 





Hilbert et al. (2007) BED (n = 162) RCT CBT, IPT 
group cohesion 
remission 
ns; FU: pos  
group climate ns 
Tasca et al. (2006) BED (n = 65) RCT PD climate binge frequency pos 
4. SELF-RELATEDNESS   
- - - - - - - - -  - - - - - - - - - 
5. IN- AND INTER-SESSION IMPACTS  
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Castonguay et al. 
(1998) 
BED (n = 75) con CBT 
pos. emotions 
remission 
early, mid: pos; late: ns 
neg. emotions early: neg; mid, late: ns 




pos. expectations pos 
recreating dialogue neg 
intensity pos 
Hoffart et al. (2010) 
BN, EDNOS 
(n = 39) 








pos. emotions pos 
neg. emotions ns 
Zeeck & Hartmann 
(2005) 




recreating dialogue pos 
6. TEMPORAL PATTERNS  
Symptom Change / Rapid Response sign: n = 18 / ns: n = 1 
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Agras et al. (2000); 
Fairburn et al. (2004) 
BN (n = 220) RCT CBT, IPT rapid response remission pos 
Doyle et al. (2010) AN (n = 65) con FBT rapid response remission pos 
Grilo & Masheb (2007) BED (n = 50) RCT SH rapid response remission pos; FU: ns 
Grilo et al. (2006) BED (n = 108) RCT CBT rapid response remission, recovery pos 
Grilo et al. (2012) BED (n = 90) RCT CBT rapid response remission pos ; FU: ns 
Forsberg et al. (2013b) AN (n = 78) RCT FBT rapid response recovery pos 
Hartmann et al. (2007) AN (n = 85) nat PD rapid response weight gain pos 
Hartmann et al. (2010) BN (n = 55) RCT PD rapid response remission pos 
Le Grange et al. (2008) 
Lock et al. (2008) 
BN (n = 80) RCT FBT, SPT rapid response remission pos 
Le Grange et al. (2012) AN (n = 121) RCT FBT, AFT rapid response remission ns 
Lund et al. (2009) AN (n = 79) nat no info available rate of weight gain weight gain pos 
Masheb & Grilo (2007) BED (n = 75) RCT SH rapid response binge frequency pos 
Munsch et al. (2012) BED (n = 52) RCT CBT rapid response 
binge frequency pos 
remission ns 
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Olmsted et al. (1996) BN (n = 166) nat CBT rapid response relapse pos 
Raykos et al. (2013) 
AN, BN, 
EDNOS (n = 
105) 
nat CBT rapid response remission pos 
Safer & Joyce (2011) BED (n = 101) RCT DBT rapid response remission pos 
Schlup et al. (2011) BED (n = 76) con CBT rapid response binge frequency short: pos; long: ns 
Tagay et al. (2010) AN (n = 121) nat no info available 
longer and greater 
initial weight loss 
weight gain pos 




Dose Effects / Duration sign: n = 13 / ns: n = 5 
Brown et al. (2013) AN (n = 65) nat CBT attendance weight gain ns 
Fichter et al. (2012) AN (n = 258) RCT CBT compliance weight gain pos 
Gorin et al. (2003) BED (n = 94) RCT CBT attendance binge frequency pos 
Gowers et al. (1994) AN (n = 20) RCT no info available attendance M-R scores pos 
Hilbert et al. (2007) BED (n = 162) RCT CBT, IPT attendance remission ns 
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Jones et al. (2007) 
AN, BN, 
EDNOS (n = 
34) 
nat CBT duration weight gain pos 
Kächele et al. (2001) 
AN, BN (n = 
1.171) 
nat PD duration recovery pos 
Le Grange et al. (2005) AN (n = 45) nat FBT, SPT short vs. long weight gain long > short 
Lock & Litt (2003) AN (n = 44) nat FBT duration weight gain neg 
Lock et al. (2005)  
Lock et al. (2006) 
AN (n = 86) RCT FBT, AFT short vs. long weight gain ns 
McHugh (2007) AN (n = 65) nat 
combined 
including FBT 
duration recovery neg  
Olmsted et al. (2003) 
AN, BN, 
EDNOS (n = 
756) 
con CBT day 4 vs. 5 
weight gain 4 > 5 
binge frequency, 
remission 
5 > 4 
purge frequency ns 




EDNOS (n = 
2.000) 
nat no info available duration remission pos; FU: ns 
Schlup et al. (2011) BED (n = 76) con CBT short vs. long 
binge frequency ns 
remission long > short; FU: ns 
Thiels et al. (2001) BN (n = 31) con SH compliance remission ns 
Thompson-Brenner & 
Westen (2005) 
BN (n = 145) nat CBT, PD duration remission pos 
Troop et al. (1996) BN (n = 55) RCT SH compliance remission pos 
Wilfley et al. (1993) BN (n = 56) RCT CBT attendance binge frequency ns 
Note. AN = anorexia nervosa; BN = bulimia nervosa; BED= binge-eating disorder; EDNOS = eating disorder not otherwise specified; RCT = 
randomized-controlled trial; nat = naturalistic study; con = controlled study; TAU = treatment as usual; FBT = family-based treatment; CBT = 
cognitive-behavioral therapy; CT = cognitive therapy; CR = cognitive restructuring; SPT = supportive psychotherapy; AFT = adolescent-
focused therapy; IPT = interpersonal psychotherapy; MET = motivation enhancement therapy; EFT = emotion-focused therapy; PD = 
psychodynamic therapy; PA = psychoanalytical therapy; CAT = cognitive-analytical therapy; SH = self-help program; out = outpatient 
treatment; in = inpatient treatment; day = day clinic treatment; ind = individual treatment; group = group treatment; relax = relaxation; nutr = 
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nutritional counseling; instr = instruction; EMA = ecological momentary assessment; M-R scores = Morgan-Russell scores; FU = follow-up; m 
= month; y = year(s); early = early phase of treatment; mid = mid-treatment phase; late = late phase of treatment; sign = significant association 
between process and (at least one) outcome variable; ns = non-significant process-outcome association; pos = positive impact on outcome; neg 
= negative impact on outcome. 
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Figure Captions 
Figure 1. The psychotherapeutic process simplified from the General Model of 
Psychotherapy (GMP) by Orlinsky et al. (2004). 
 
Figure 2. PRISMA flow chart for identification and screening of relevant studies. 
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